Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-weekly Yipei growth hormone vs daily rhGH in children born small for gestational age
CTR20255010Phase 3Active
- Sponsor
- Xiamen Tebao Biological Engineering Co., Ltd.
- Start
- Dec 2025
- Modality
- PEGylated Peptides → Modified Peptides → Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of inpegsomatropin in growth disorder, sponsored by Xiamen Tebao Biological Engineering Co., Ltd.. Started Dec 2025; status: active.
02
Drugs
inpegsomatropin
03
Conditions
growth disorder
Beyond the preview
Go deeper on CTR20255010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255010.